The DOI matches its Crossref record.
Biological and molecular characteristics of the premalignant mouse mammary gland
Abstract
Preneoplastic lesions in murine mammary tumorigenesis have been extensively investigated over the past 50 years. The two general types of lesions that have malignant potential are the alveolar hyperplasias represented by the classical hyperplastic alveolar nodule (HAN) and the ductal hyperplasias (DHs) represented by usual DH and ductal carcinoma in situ (DCIS). The former type of lesion is induced by viral, chemical and hormonal agents; the latter by chemical agents and specific genetic alterations. Individual animal models have been utilized to elucidate the basic biological properties of the lesions and some of the basic molecular alterations. The biological phenotype of the two types of lesions include immortalization and epithelial hyperplasia. The DHs are distinguished from the alveolar hyperplasias by their pattern of epithelial hyperplasia, extent of ovarian hormone dependence, activation of telomerase and presence of aneuploidy. The molecular alterations underlying mammary epithelial hyperplasia are numerous and dependent on the particular animal model. An important issue is how faithfully any of these models mimic human premalignant progression. A minimal set of criteria is proposed that includes morphological progression, hormone dependence and genetic instability. Analogous hyperplasias from several defined genetic models, adequately characterized at the biological and molecular levels, would provide appropriate models for testing chemopreventive agents and for el…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Dab2 expression is lost in breast cancer and in carcinogen-induced rodent mammary tumors.
“An interest to examine a potential role of Dab2 in mammary glands was prompted by the findings that Dab2 expression is lost in breast cancer (Sheng et al., 2000b) and in carcinogen-induced rodent mammary tumors (Schwahn and Medina, 1998; Medina, 2002).”
From Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice (2016) · cites this paper as Medina, 2002
Citations
Cited by
Sorted by citations
Chromosome aberrations in solid tumors
Albertson, D. G., Collins, C., McCormick, F., & Gray, J. W. (2003) · Nature Genetics · doi:10.1038/ng1215 · Cited by 812
Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice
Tao, W., Moore, R., Smith, E. R., & Xu, X.-X. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00129 · Cited by 43
Metadata
- Authors
- Medina, D.
- Venue
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Published
- 2002-10-02
- Volume
- 1603
- Issue
- 1
- Pages
- 1-9
- ISSN
- 0304-419X
- Cited by
- 9
- References
- 0
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review